Induction of chronic inflammatory arthropathy and mesenchymal tumors in rats infected with HTLV-I

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 5, 1997, Pages 380-392

  Kira, Jun Ichi ^a   Yamasaki, Kenji ^a   Yamamoto, Ichiro ^a   Mizusawa, Hidehiro ^d   Yoshino, Shin ^c   Kusunoki, Susumu ^e   Yoshida, Tsutomu ^f   Koyanagi, Yoshio ^d   Tanaka, Yuetsu ^g   Kawano, Yuji ^a   Nakamura, Minoru ^b   Tsuneyoshi, Masazumi ^a   Yamamoto, Naoki ^d   Kobayashi, Takuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f FUJIREBIO INC   (Japan)

^g KITASATO UNIVERSITY   (Japan)

Author keywords

Arthritis; HTLV I; Mesenchymal tumor; Tax protein; Type II collagen

Indexed keywords

AUTOANTIBODY; COLLAGEN ANTIBODY; COLLAGEN TYPE 2; CYCLOPHOSPHAMIDE; MESSENGER RNA; VIRUS DNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; AUTOIMMUNITY; CELL MEDIATED CYTOTOXICITY; CHRONIC ARTHRITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE CULTURE; MESENCHYME; NEWBORN; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; SPLEEN CELL; T CELL LEUKEMIA; TUMOR;

ANIMALIA; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; TUMOR VIRUS;

EID: 13144277618     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199712150-00012     Document Type: Article

References (60)

1. Itoyama Y, Kira J, Fujii N, Goto I, Yamamoto N. Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy. Ann Neurol 1989;26:257-62.
2. Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin DE. Immunological studies in tropical spastic paraparesis. Ann Neurol 1990;27:149-6.
3. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
4. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann Neurol 1987;21:117-22.
5. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989;1:441.
6. Sugimoto M, Nakashima H, Watanabe S, et al. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987;2:1220.
7. Mochizuki M, Watanabe T, Yamaguchi K, et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. J Infect Dis 1992;166:943-4.
8. Vernant J-C, Buisson G, Magdeleine J, et al. T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome. Lancet 1988; 1:177.
9. Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjögren syndrome in HTLV-I tax transgenic mice. Nature 1989; 341:72-1
10. Iwakura Y, Tosu M, Yoshida E, et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991;253:1026-8.
11. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987;237:1324-9.
12. Iwakura Y, Saijo S, Kioka Y, et al. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J Immunol 1995;155:1588-98.
13. Ishiguro N, Abe M, Seto K, et al. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J Exp Med 1992;176:981-9.
14. Kushida S, Mizusawa H, Matsumura M, et al. High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells. J Virol 1994; 68:7221-6.
15. Seto K, Abe M, Ohya O, et al. A rat model of HTLV-I infection: development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis. Acta Neuropathol 1995; 89:483-90.
16. Tomaru U, Ikeda H, Ohya O, et al. Human T lymphocyte virus type I-induced myeloneuropathy in rats: implication of local activation of the pX and tumor necrosis factor-α genes in pathogenesis. J Infect Dis 1996;174:318-23.
17. Miyoshi I, Kubonishi I, Yoshimoto S, et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981;294:770-1.
18. Kira J, Itoyama Y, Goto I. Surface phenotypic changes of spleen cells on acquisition of encephalitogenicity. J Neuroimmunol 1987; 16:365-79.
19. Wood FD, Pearson CM, Tanaka A. Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy 1969;35:456-67.
20. Kira J, Koyanagi Y, Yamada T, et al. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 1991;29:194-201.
21. Yu F, Itoyama Y, Kira J, et al. TNF-β produced by human T lymphotropic virus type I-infected cells influences the proliferation of human endothelial cells and fibroblasts. J Immunol 1994;152: 5930-8.
22. Suzuki J, Kira J, Baba E, et al. The association of antibodies against human T cell lymphotropic virus type I (HTLV-I) pX gene mutant products with HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 1996;173:1115-22.
23. Kira J, Deibler GE, Krutzsch HC, Martenson RE. Amino acid sequence of porcine myelin basic protein. J Neurochem 1985;44: 134-42.
24. Adelmann M, Wood J, Benzel I, et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 1995;63:17-27.
25. Kusunoki S, Chiba A, Kon K, et al. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-6.
26. Tanaka Y, Isobe A, Masuda M, et al. Immunogenicity of human T cell leukemia virus tye-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system. J Immunol 1991;147:3646-52.
27. Kira J, Itoyama Y, Goto I. Generation of CD4+ blastoid T cells in recipients of BP/IFA-sensitized spleen cells. Cell Immunol 1990; 128:130-1.
28. Ibrahim F, Fiette L, Gessain A, Buisson N, de Thé G, Bomford R. Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location. Int J Cancer 1994;58:446-51.
29. Pour P, Ii Y, Althoff J. Comparative studies on spontaneous tumor incidence based on systematic histologic examination of rat and hamster strains of the same colony. Prog Exp Tumor Res 1979; 24:199-206.
30. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 1995;86:3619-39.
31. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 1990;87: 1071-5.
32. Dhib-Jalbut S, Hoffman PM, Yamabe T, et al. Extracellular human T-cell lymphotropic virus type I tax protein induces cytokine production in adult human microglial cells. Ann Neurol 1994;36:787-90.
33. Dropcho EJ, Richman DP, Antel JP, Arnason BGW. Defective mitogenic responses in myasthenia gravis and multiple sclerosis. Ann Neurol 1982;11:456-62.
34. Itoyama Y, Minato S, Kira J, et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 1988;38:1302-7.
35. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
36. Yoo TJ, Kim S-Y, Stuart JM, et al. Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med 1988;168: 777-82.
37. Stuart JM, Dixon FJ. Serum transfer of collagen-induced arthritis in mice. J Exp Med 1983;158:378-92.
38. Malmstrom V, Michaelsson E, Burkhardt H, Mattsson R, Vuorio E, Holmdahl R. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci USA 1996;93:4480-5.
39. Myers KJ, Sprent J, Dougherty JP, Ron Y. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 1992;41:1-8.
40. Roth GA, Roytta M, Yu RK, Raine CS, Bornstein MB. Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures. Brain Res 1985;339:9-18.
41. Meeson AP, Piddlesden S, Morgan BP, Reynolds R. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis. Exp Neurol 1994;129:299-310.
42. Genain, CP, Nguyen M-H, Letvin NL, et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995;96:2966-74.
43. Hahn AF, Feasby TE, Wilkie L, Lovgren D. Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis. Muscle Nerve 1993;16:1174-80.
44. Kira J, Itoyama Y, Koyanagi Y, et al. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol 1992;31:39-45.
45. Lehky T, Fox CE, Koenig S, et al. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995;37: 167-5.
46. Rosenblatt JD, Tomkins P, Rosenthal M, et al. Progressive spastic myelopathy in a patient co-infected with HIV-I and HTLV-II: autoantibodies to the human homologue of rig in blood and cerebrospinal fluid. AIDS 1992;6:1151-8.
47. Hara H, Morita M, Iwaki T, et al. Detection of human T lymphotropic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor Vβ CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Exp Med 1994;180:831-9.
48. Gleeson PA, Toh B-H, van Driel IR. Organ-specific autoimmunity induced by lymphopenia. Immunol Rev 1996;149:97-125.
49. Davidoff AN, Mendelow BV. C-myc expression is down-regulated in mafosfamide-treated HL-60 cells undergoing apoptosis. Anticancer Res 1993;13:1167-70.
50. Meyn RE, Stephens LC, Hunter NR, Milas L. Induction of apoptosis in murine tumors by cyclophosphamide. Cancer Chemother Pharmacol 1994;33:410-4.
51. Dole MG, Jasty R, Cooper MJ, Thompson CB, Nunez G, Castle VP. Bcl-XL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 1995;55:2576-82.
52. Kuroda Y, Takashima H, Yukitake M, Sakemi T. Development of HTLV-I-associated myelopathy after blood transfusion in a patient with aplastic anemia and a recipient of renal transplant. J Neurol Sci 1991;109:196-9.
53. Rosenblum MK, Brew BJ, Hahn B, et al. Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome. Am J Pathol 1992;23:513-9.
54. Kira J, Koyanagi Y, Yamada T, et al. Sequence heterogeneity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol J 1994;36:149-56.
55. Renjifo B, Borrero I, Essex M. Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy. J Virol 1995;69:2611-6.
56. Niewiesk S, Daenke S, Parker CE, et al. Naturally occurring variants of human T-cell leukemia virus type I tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of tax. J Virol 1995;69:2649-53.
57. Gessain A, Gallo RC, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol 1992;66:2288-95.
58. Mahieux R, de Thé G, Gessain A. The tax mutation at nucleotide 7959 of human T-cell leukemia virus type 1 (HTLV-1) is not associated with tropical spastic paraparesis/HTLV-1-associated myelopathy but is linked to the cosmopolitan molecular genotype. J Virol 1995;69:5925-7.
59. Osame M, Janssen R, Kubota H, et al. Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 1990;28:50-6.
60. Kaplan JE, Litchfield B, Rouault C, et al. HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient. Neurology 1991;41:192-7.